ACE Inhibitors Market Set to Grow to $9.6 Billion by 2029: Key Drivers and Trends

Pushing the Boundaries with ACE Inhibitor Advances: Projections Predict Its Global Market Growth to $9.6 Billion by 2029

What Is The Projected Market Size Of The Global ACE Inhibitors Market And Its Growth Rate?

The key projections for the ACE Inhibitors market are as follows:

- A record growth from $7.15 billion in 2024 to $7.48 billion in 2025 is expected at a CAGR of 4.6%.
- The market is expected to enjoy tremendous growth, hitting $9.6 billion in 2029 at a CAGR of 6.4%.
- The growth will be primarily driven by factors such as increased incidence of cardiovascular disease, advancements in treatment and growing global healthcare access.

What Is Driving The Growth In The ACE Inhibitors Market?

The growth of the ACE inhibitors market is driven by the increasing prevalence of hypertension disorders globally. ACE inhibitors work to relax blood vessels, thereby lowering blood pressure and improving blood flow. According to a report by the World Health Organization, nearly 1.28 billion adults aged between 30 and 79 were affected by hypertension worldwide as of March 2023. Two-thirds of these patients live in low- and middle-income nations. With 46% of people with hypertension not having a diagnosis, the demand for ACE inhibitors is bound to increase, driving the market growth.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10671&type=smp

Who Are the Key Players Driving ACE Inhibitors Market Growth?

Some of the key players in the ACE inhibitors market are:

- Pfizer Inc.
- Novartis AG
- Johnson & Johnson Private Limited
- Merck KGaA
- Sanofi S.A.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Co.
- Takeda Pharmaceuticals Company

What Are The Key Trends In The ACE Inhibitors Market?

Key trends emerging in the ACE Inhibitors market include:

- Growing focus on kidney protection.
- Preference for renin-angiotensin system inhibitors.
- Rising pressure of generic competition and price.
- Increase in patient-centric approaches in healthcare.

What Are The Segments Of The Global ACE Inhibitors Market?

The segments of the global ACE Inhibitors market are:

- By Type: Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents
- By Drug: Ramipril, Enalapril, Benazepril, Fosinopril, Captopril, Moexipril, Other Drugs
- By Dosage Form: Oral Tablets, Oral Solutions
- By Application: Heart Failure, Chronic Kidney Disease, Hypertension, Diabetes, Heart Attack, Other Applications
- By End-Users: Hospitals, Online Drug Stores, Other End-Users

Which Region Leads The ACE Inhibitors Market?

North America was the dominant region in the ACE Inhibitors market in 2024 while the Asia-Pacific region is projected to be the fastest-growing market in the coming years. The ACE Inhibitors market spans across various regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/ace-inhibitors-global-market-report

What Is Covered In The ACE Inhibitors Market Global Market Report?

- Market Size Analysis: Analyze the ACE Inhibitors Market size by key regions, countries, product types, and applications.

- Market Segmentation Analysis: Identify various subsegments within the ACE Inhibitors Market for effective categorization.

- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.

- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.

- Market Contribution: Evaluate contributions of different segments to the overall ACE Inhibitors Market growth.

- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.

- Industry Challenges: Analyze challenges and risks affecting the ACE Inhibitors Market.

- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/Customise?id=10671&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.